Universal Beteiligungs und Servicegesellschaft mbH Sells 116,980 Shares of Kenvue Inc. $KVUE

Universal Beteiligungs und Servicegesellschaft mbH reduced its holdings in Kenvue Inc. (NYSE:KVUE) by 10.6% in the fourth quarter, HoldingsChannel reports. The firm owned 991,378 shares of the company’s stock after selling 116,980 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Kenvue were worth $17,150,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the business. Optas LLC bought a new stake in Kenvue in the fourth quarter worth approximately $192,000. Mayar Capital Ltd. increased its holdings in Kenvue by 56.4% in the fourth quarter. Mayar Capital Ltd. now owns 726,716 shares of the company’s stock worth $12,536,000 after purchasing an additional 262,000 shares in the last quarter. Proffitt & Goodson Inc. increased its holdings in Kenvue by 241.4% in the fourth quarter. Proffitt & Goodson Inc. now owns 29,885 shares of the company’s stock worth $516,000 after purchasing an additional 21,132 shares in the last quarter. VCI Wealth Management LLC increased its holdings in Kenvue by 55.1% in the fourth quarter. VCI Wealth Management LLC now owns 64,203 shares of the company’s stock worth $1,108,000 after purchasing an additional 22,802 shares in the last quarter. Finally, Institute for Wealth Management LLC. bought a new stake in Kenvue in the fourth quarter worth approximately $1,093,000. 97.64% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have recently commented on KVUE shares. Canaccord Genuity Group boosted their price objective on Kenvue from $17.00 to $18.00 and gave the company a “hold” rating in a report on Wednesday, February 18th. Barclays decreased their price objective on Kenvue from $19.00 to $18.00 and set an “equal weight” rating for the company in a report on Tuesday, April 14th. Argus upgraded Kenvue to a “hold” rating in a report on Friday, March 6th. Jefferies Financial Group downgraded Kenvue from a “buy” rating to a “hold” rating and decreased their price objective for the company from $23.00 to $18.00 in a report on Friday, January 30th. Finally, UBS Group decreased their price objective on Kenvue from $19.00 to $18.00 and set a “neutral” rating for the company in a report on Tuesday, April 7th. Three research analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $19.33.

Kenvue Stock Down 0.0%

Shares of NYSE:KVUE opened at $17.49 on Friday. The stock has a market cap of $33.57 billion, a price-to-earnings ratio of 22.71, a PEG ratio of 3.97 and a beta of 0.61. The company has a quick ratio of 0.68, a current ratio of 0.96 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 12-month low of $14.02 and a 12-month high of $25.17. The business’s 50 day moving average is $17.82 and its 200 day moving average is $17.15.

Kenvue (NYSE:KVUE) last announced its earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.22 by $0.05. The company had revenue of $3.78 billion for the quarter, compared to analysts’ expectations of $3.68 billion. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.Kenvue’s quarterly revenue was up 3.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.26 earnings per share. On average, sell-side analysts forecast that Kenvue Inc. will post 1.1 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, February 25th. Investors of record on Wednesday, February 11th were given a dividend of $0.2075 per share. The ex-dividend date of this dividend was Wednesday, February 11th. This represents a $0.83 annualized dividend and a dividend yield of 4.7%. Kenvue’s payout ratio is presently 107.79%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.